How are Novartis and NHS England collaborating and what does this mean for population health and the UK Healthcare system?
Novartis and NHS England are working together with a view to addressing one of the UK’s most intractable health challenges, cardiovascular disease (CVD).
The collaboration consists of the following:
1. Subject to MHRA approval and a successful NICE appraisal, introducing a first-in-class medicine into the lipid management pathway using Population Health Management (PHM) as a framework and technique to deliver the molecule
2. Novartis delivering a large-scale clinical trial in collaboration with Oxford University, looking at the primary prevention of cardiovascular disease.
3. Creating an industry and academic consortium to look at manufacturing synergies that could improve the efficiency and scale at which the UK can manufacture oligonucleotide medicines.
“I am really proud of the partnership that Novartis UK has built with NHS England and the UK government that is aligned with our ambition to build a healthier tomorrow for patients by expanding the frontiers of healthcare and reimagining medicine. This pioneering collaboration has the potential to make a significant contribution to the clear goals outlined in the NHS long-term plan and improve patient outcomes. We aspire to pave the way for similar collaborations amongst key stakeholders within the life sciences industry to enable greater uptake of innovations into healthcare systems and improve access to novel therapies.”
- Chinmay Bhatt, Managing Director Novartis Pharmaceuticals UK
What is population health?
Traditionally, the NHS model has been to treat people episodically – often in hospital when they become sick. In January 2019, the NHS launched the Long Term Plan setting out priorities for delivering healthcare over the next ten years. This plan included a number of initiatives and solutions designed to deliver integrated care to improve the overall health of the population.
This NHS Population Health initiative is a framework that starts with data. Data offers many insights into patient groups across the UK and allows a better understanding into what factors, such as an individual’s income or education, influence the overall health and well-being of different community groups - and what can be done to improve it.
Novartis understands the important role that Population Health plays in improving the physical and mental health outcomes for communities across the UK. With a scientific, data-led approach, Novartis aim to contribute and support the NHS to accelerate the long-term plan and improve the cardiovascular health of communities across the UK. By focusing on providing preventative care, while reducing health inequalities across the nation, Novartis aims to drive a shift in action towards meeting the ever-changing needs that healthcare demands by reducing the burden on the NHS and improving the overall health of the population.
What is Population Health Management (PHM)?
Population Health Management (PHM) is an emerging data-driven technique within the Population Health paradigm. It is a process that leverages the proactive use of data to address the health-related needs of a defined population through various interventions.
Novartis, in collaboration with NHS England and local health and care partnerships, are working together with the aim of providing better healthcare to those with long-term conditions, using PHM approaches. Using historic and current data, our goal is to improve health outcomes, reduce the health inequality gap and, with the help of local partnerships, provide healthier lives for those living with long-term diseases, such as diabetes, asthma and heart disease.
It’s our goal to understand people’s health on a new level, so that we can support positive health outcomes now and in the future. Working in close collaboration with multiple organisations we are working towards improving the population’s healthcare needs by sharing resources, skills and goals.
This will allow the UK to better tailor care provision, based on real-world data. We can do this within each area of the UK to address each individual localities healthcare needs.
What factors affect Population Health?
Useful links and resources on population health and population health management: